Want to see MMS full AI Analyst Report?
MMS Stock Chart & Stats
$86.22
-$0.19(-0.25%)
At close: 4:00 PM EST
$86.22
-$0.19(-0.25%)
Day’s Range― - ―
52-Week Range$52.73 - $100.00
Previous CloseN/A
Volume111.76K
Average Volume (3M)737.90K
Market Cap
$3.14B
Enterprise Value$4.88K
Total Cash (Recent Filing)$244.70M
Total Debt (Recent Filing)$1.63B
Price to Earnings (P/E)8.9
Beta0.44
Next Earnings
Aug 06, 2026EPS Estimate
2.21Next Dividend Ex-DateN/A
Dividend Yield2.11%
Share Statistics
EPS (TTM)6.73
Shares Outstanding52,540,363
10 Day Avg. Volume619,689
30 Day Avg. Volume737,896
Financial Highlights & Ratios
PEG Ratio1.56
Price to Book (P/B)3.13
Price to Sales (P/S)0.97
P/FCF Ratio14.33
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$100.00Price Target Upside15.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)8.44
Revenue Forecast (FY)$5.30B
Bulls Say, Bears Say
Bulls Say
Margin ExpansionSustained margin expansion to ~7% net and 24.6% gross reflects structural improvement in service delivery and cost control. Combined with management's stated AI/automation gains, higher margins indicate durable operating leverage that can persist as contracts scale and technology reduces unit labor intensity.
Free Cash Flow ConversionHigh FCF conversion (~90% of net income) demonstrates the business reliably turns profits into cash. This strengthens funding for buybacks, investment, or deleveraging, and provides a buffer against timing swings in government collections over the next several quarters.
De‑risked Balance SheetMarkedly lower leverage and improving ROE give management financial flexibility for opportunistic buybacks and disciplined M&A. A de‑risked balance sheet reduces refinancing and covenant risk and supports stability through contract timing variability over the medium term.
Bears Say
Top-line Momentum WeaknessA decline in trailing revenue signals structural headwinds from procurement cadence and tougher comps (e.g., prior disaster work). Slower contract awards and lumpy program starts can constrain durable revenue growth for multiple quarters despite margin gains.
Elevated DSO / Receivables TimingPersistently high DSO (78 days) and administrative collection delays point to cash‑flow volatility. Management expanded receivables facilities, but timing risk can cause recurring quarter‑end liquidity swings and complicate reliable FCF pacing over 2–6 months.
Procurement Timing & Low Book‑to‑BillA sustained book‑to‑bill ~0.5x signals slower award flow and increased protest activity, delaying revenue recognition and backlog conversion. This structural procurement timing issue can depress near‑term growth and keep bookings lumpy across multiple quarters.
Maximus News
MMS FAQ
What was Maximus’s price range in the past 12 months?
Maximus lowest stock price was $52.73 and its highest was $100.00 in the past 12 months.
What is Maximus’s market cap?
Maximus’s market cap is $3.14B.
When is Maximus’s upcoming earnings report date?
Maximus’s upcoming earnings report date is Aug 06, 2026 which is in 11 days.
How were Maximus’s earnings last quarter?
Maximus released its earnings results on May 07, 2026. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.965 by $0.105.
Is Maximus overvalued?
According to Wall Street analysts Maximus’s price is currently Undervalued.
Does Maximus pay dividends?
Maximus pays a Quarterly dividend of $0.33 which represents an annual dividend yield of 2.11%. See more information on Maximus dividends here
What is Maximus’s EPS estimate?
Maximus’s EPS estimate is 2.21.
How many shares outstanding does Maximus have?
Maximus has 52,540,363 shares outstanding.
What happened to Maximus’s price movement after its last earnings report?
Maximus reported an EPS of $2.07 in its last earnings report, beating expectations of $1.965. Following the earnings report the stock price went up 4.238%.
Which hedge fund is a major shareholder of Maximus?
Currently, no hedge funds are holding shares in MMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Maximus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$100.00 (15.98% Upside)
$100.00 (15.98% Upside)
Blogger Sentiment
Bullish
MMS Sentiment 70%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 250.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 13.4%
Last 30 Days ▲ 13.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.27%
12-Months-Change
Fundamentals
Return on Equity
2.11%
Trailing 12-Months
Asset Growth
0.94%
Trailing 12-Months
Company Description
Maximus
Maximus, Inc. specializes in delivering business process services (BPS) tailored for governmental health and human welfare initiatives. Its operations are structured into three main divisions: U.S. Services, U.S. Federal Services, and International Services. The U.S. Services division delivers a wide array of BPS solutions to state and local government programs across the United States. These offerings encompass program administration, handling appeals and evaluations, and providing specialized consulting. Key programs supported include the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, and child support initiatives, alongside Preadmission Screening and Resident Reviews and Independent Developmental Disability assessments. Furthermore, this segment facilitates program eligibility and enrollment, operates centralized multilingual contact centers with multichannel and digital self-service capabilities, offers application assistance and impartial health plan selection guidance, and conducts outreach, education, eligibility determination, enrollment, and redetermination for beneficiaries. It also performs person-centered independent assessments for disability, long-term illness, and other health conditions, complemented by targeted consulting services. The U.S. Federal Services segment focuses on providing critical support to federal government agencies. Its services include establishing and managing centralized citizen engagement centers, overseeing document and record management, offering case management and direct citizen support, and delivering consumer education. This division also handles independent medical reviews, appeals for worker's compensation benefits, Medicare and Medicaid appeals, and eligibility appeals for the federal marketplace. Additionally, it contributes to the modernization of systems and IT infrastructure, provides operational support for infrastructure, offers software development, operations, and management, and specializes in data analytics. Internationally, the company's "Outside the U.S." segment delivers BPS offerings to both governmental bodies and commercial enterprises. These services include health and disability evaluations, the administration of employment programs, and various other services aimed at assisting job seekers. Established in 1975, Maximus, Inc. maintains its corporate headquarters in Tysons, Virginia.
MMS Stock 12 Month Forecast
Average Price Target
$100.00
▲(15.98% Upside)
Technical Analysis
Ownership Overview
2.00% Insiders
36.65% Mutual Funds
5.50% Other Institutional Investors
25.42% Public Companies and
Individual Investors






